GT Urological, LLC is a medical device company based in Minneapolis, Minnesota that develops, manufactures, markets and distributes medical device products for the urinary incontinence market.

Urinary incontinence is an involuntary condition in which a person is unable to hold urine and prevent its leakage. This urologic condition imposes a significant financial burden on individuals, their families, and healthcare organizations. The estimated societal cost of incontinence for individuals 65 years and older is $26.3 billion or $3,565 per individual. The US urology market is expected to experience strong growth, driven by a number of factors. These include the aging US population, an increasingly knowledgeable consuming public, favorable reimbursement, and an expanding portfolio of treatment options.

Today, more than 13 million Americans spend over $2 billion on products like adult diapers, catheter collection systems, penile clamps and absorbent pads to treat urinary incontinence. The existing treatment and management options require patients to make difficult tradeoffs between quality of life (QOL) and efficacy. GTU solves these problems by developing products that allow patients to resume a normal lifestyle.